1-4 of 4
Barbara Vanhoecke, PhD
Close
Sort by
Journal Articles

Xanthohumol: A New Potential Proteasome Inhibitor That Activates the Pro-Apoptotic Arm of the Unfolded Protein Response in B-CLL Cells.

Sofie Lust, Barbara VanHoecke, PhD, Mireille Van Gele, PhD, Jerina Boelens, MD, Jan Philippé, MD PhD, Petra Vincken, Marc Bracke, MD PhD, Martine Poelman, MD, Fritz Offner, MDPhD
Journal: Blood
Blood (2007) 110 (11): 4694.
https://doi.org/10.1182/blood.V110.11.4694.4694
Published: 2007
Journal Articles

Xanthohumol Induces Apoptosis in B-CLL In Vitro by Sustained Endoplasmic Reticulum Stress and Inhibition of NFκ-B.

Sofie Lust, Barbara Vanhoecke, PhD, Mireille Van Gele, Mary Kaileh, Jerina Boelens, MD, Martine Poelman, MD, Wim VandenBerghe, PhD, Jan Philippé, MD PhD, Fritz Offner, MD PhD
Journal: Blood
Blood (2006) 108 (11): 4979.
https://doi.org/10.1182/blood.V108.11.4979.4979
Published: 2006
Journal Articles

Synergism between Rituximab, Xanthohumol and Simvastatin in B-NHL Lines In Vitro.

Ilse Joncheere, Jerina Boelens, MD, Sofie Lust, Barbara Vanhoecke, PhD, Wim Vandenberghe, PhD, Martine Poelman, MD, Fritz Offner, MDPhD
Journal: Blood
Blood (2006) 108 (11): 4750.
https://doi.org/10.1182/blood.V108.11.4750.4750
Published: 2006
Journal Articles

Xanthohumol Induces Apoptosis in B-CLL Mediated by Caspase 9 Following Downregulation of bcl-xL and mcl-1.

Barbara Vanhoecke, PhD, Sofie Lust, Ann Janssens, MD, Jan Philippe, MD, PhD, Marc Bracke, MD, PhD, Fritz Offner, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5028.
https://doi.org/10.1182/blood.V106.11.5028.5028
Published: 2005